Ignite Creation Date:
2024-05-06 @ 1:59 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01949194
Status:
UNKNOWN
Last Update Posted:
2018-08-10
First Post:
2013-09-11
Brief Title:
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
Sponsor:
Gerald Batist
Organization:
Jewish General Hospital
Organization Data
Organization:
Jewish General Hospital
Class:
OTHER
Study ID:
QCROC-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gerald Batist
Lead Sponsor Class:
OTHER
Responsible Party:
Gerald Batist
Responsible Party Title:
Medical Oncologist Director Segal Cancer Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Jewish General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Quebec Clinical Research Organization in Cancer | OTHER |
| Bayer | INDUSTRY |